Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 42,524 results for: Eras

Clear keywords
Showing: 981 - 1000 of 42524 results

  1. Click editor utilizing mSA for template recruitment and ePhi29 DNA polymerase - pCMV-T7-mSA-nCas9-ePhi29 (JO1398)

    Plasmid
    #217803
    Purpose
    Variant CE1 construct with mSA for template recruitment and ePhi29(D169A) DNA pol, expressed from CMV or T7 promoters.
    Depositor
    Benjamin Kleinstiver
    Article
    Ferreira da Silva et al Nat Biotechnol. 2024 Jul 22. doi: 10.103
    Insert
    mSA-linker-SV40NLS-nSpCas9-BPNLS-ePhi29-BPNLS
    Use
    CRISPR; In vitro transcription; t7 promoter
    Tags
    BPNLS
    Expression
    Mammalian
    Mutation
    nSpCas9(H840A); Phi29(D169A/M8R/V51A/M97T/G197D/E…
    Promoter
    CMV and T7
    Available Since
    Sept. 6, 2024
    Availability
    Academic Institutions and Nonprofits only
    217803-plasmid-map-sequence-id-432890

    Enlarge

  2. scCHyMErA-Seq Exon Deletion Library 1

    Pooled Library
    #237473
    Purpose
    Enables high-throughput identification of frame-preserving exons that influence transcriptional phenotypes, building on the CHyMErA system (Nature Biotechnology, 2020; PMID: 32249828).
    Depositor
    Thomas Gonatopoulos-Pournatzis
    Article
    Kumari et al Nat Commun. 2026 Feb 3;17(1):1218. doi:
    Expression
    Mammalian
    Species
    Homo sapiens
    Use
    CRISPR and Lentiviral
    Available Since
    Oct. 28, 2025
    Availability
    Academic Institutions and Nonprofits only

  4. CHyMErA LbCas12a Nuclease Optimization hgRNA Library

    Pooled Library
    #209734
    Purpose
    CHyMErA Cas12a Nuclease Optimization hgRNA Libraries allows assessment and comparison of the efficacy of different LbCas12a nucleases in the context of the Cas9-Cas12a CHyMErA system.
    Depositor
    Thomas Gonatopoulos-Pournatzis
    Article
    Xiao et al Mol Cell. 2024 Jul 11;84(13):2553-2572.e
    Expression
    Mammalian
    Use
    CRISPR and Lentiviral
    Available Since
    June 20, 2024
    Availability
    Academic Institutions and Nonprofits only

  5. CHyMErA AsCas12a Nuclease Optimization hgRNA Library

    Pooled Library
    #209735
    Purpose
    CHyMErA Cas12a Nuclease Optimization hgRNA Libraries allows assessment and comparison of the efficacy of different AsCas12a nucleases in the context of the Cas9-Cas12a CHyMErA system.
    Depositor
    Thomas Gonatopoulos-Pournatzis
    Article
    Xiao et al Mol Cell. 2024 Jul 11;84(13):2553-2572.e
    Expression
    Mammalian
    Use
    CRISPR and Lentiviral
    Available Since
    June 20, 2024
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-hsyn-GRAB_DA2m (AAV9)

    Viral Prep
    #140553-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hsyn-GRAB_DA2m (#140553). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_DA2m plasmid DNA. Synapsin-driven expression of 2nd generation medium affinity dopamine sensor GRAB_rDA2m. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Sun et al Nat Methods. 2020 Nov;17(11):1156-1166.
    Promoter
    Syn
    Available Since
    Aug. 31, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-ATLASsnCre (AAV5)

    Viral Prep
    #232351-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-ATLASsnCre (#232351). In addition to the viral particles, you will also receive purified pAAV-ATLASsnCre plasmid DNA. Syn-driven, ATLASsnCre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-DIO-BACE-HA (AAV8)

    Viral Prep
    #232353-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-DIO-BACE-HA (#232353). In addition to the viral particles, you will also receive purified pAAV-DIO-BACE-HA plasmid DNA. Syn-driven, Beta-Secretase expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-DIO-ATLASsnFlp (AAV8)

    Viral Prep
    #232352-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-DIO-ATLASsnFlp (#232352). In addition to the viral particles, you will also receive purified pAAV-DIO-ATLASsnFlp plasmid DNA. Syn-driven, ATLASsnFlp expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-DIO-ATLASsnFlp (AAV5)

    Viral Prep
    #232352-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-DIO-ATLASsnFlp (#232352). In addition to the viral particles, you will also receive purified pAAV-DIO-ATLASsnFlp plasmid DNA. Syn-driven, ATLASsnFlp expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-hsyn-GRAB_DA2h (AAV9)

    Viral Prep
    #140554-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hsyn-GRAB_DA2h (#140554). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_DA2h plasmid DNA. Synapsin-driven expression of high-affinity GRAB_DA2h dopamine sensor in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Sun et al Nat Methods. 2020 Nov;17(11):1156-1166.
    Promoter
    Syn
    Available Since
    Aug. 9, 2021
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (AAV8)

    Viral Prep
    #228902-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (#228902). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine plasmid DNA. CAG-driven, Cre dependent expression of a peripherally restricted DREADD. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Article
    Kang et al Cell. 2024 Dec 26;187(26):7433-7449.e20.
    Promoter
    Chicken Beta Actin
    Tags
    mCitrine
    Available Since
    Oct. 8, 2025
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV.GFA104.PI.eGFP.WPRE.bGH (AAV5)

    Viral Prep
    #100896-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFA104.PI.eGFP.WPRE.bGH (#100896). In addition to the viral particles, you will also receive purified pAAV.GFA104.PI.eGFP.WPRE.bGH plasmid DNA. GFA104-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Philip Haydon
    Article
    Ortinski et al Nat Neurosci. 2010 May;13(5):584-91. doi
    Promoter
    GFA104 (GFAP promoter)
    Tags
    EGFP
    Available Since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-TBG-ER-TurboID (AAV8)

    Viral Prep
    #149415-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-TBG-ER-TurboID (#149415). In addition to the viral particles, you will also receive purified pAAV-TBG-ER-TurboID plasmid DNA. TBG-driven expression of ER-localized TurboID (with HA and V5 tag). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jonathan Long
    Article
    Wei et al Nat Chem Biol. 2021 Mar;17(3):326-334. d
    Promoter
    TBG
    Available Since
    Aug. 6, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-RSV-SpCas9 (AAV8)

    Viral Prep
    #85450-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-RSV-SpCas9 (#85450). In addition to the viral particles, you will also receive purified pAAV-RSV-SpCas9 plasmid DNA. RSV-driven expression of SpCas9. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hetian Lei
    Article
    Duan et al J Biol Chem. 2016 May 31. pii: jbc.M116.
    Promoter
    pRSV
    Available Since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-FLEx-ER-TurboID (AAV8)

    Viral Prep
    #160857-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-FLEx-ER-TurboID (#160857). In addition to the viral particles, you will also receive purified pAAV-FLEx-ER-TurboID plasmid DNA. CMV-driven, Cre-dependent expression of ER-localized TurboID (with HA and V5 tag). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jonathan Long
    Article
    Wei et al Nat Chem Biol. 2021 Mar;17(3):326-334. d
    Promoter
    CAG
    Available Since
    Aug. 6, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-CAG-tTA (AAV2)

    Viral Prep
    #99118-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CAG-tTA (#99118). In addition to the viral particles, you will also receive purified pAAV-CAG-tTA plasmid DNA. CAG-driven expression of tetracycline-controlled transactivator (tTA). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.
    Promoter
    CAG
    Available Since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only
Showing: 981 - 1000 of 42524 results